Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials

BACKGROUND: Administration of glucocorticoids might reduce mortality in patients with severe COVID-19 but have adverse cardiometabolic effects. OBJECTIVES: to investigate the effect of systemic administration of glucocorticoids on cardiovascular complications and all-cause mortality in patients hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Caiazzo, Elisabetta, Rezig, Asma O.M., Bruzzese, Dario, Ialenti, Armando, Cicala, Carla, Cleland, John G.F., Guzik, Tomasz J., Maffia, Pasquale, Pellicori, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719379/
https://www.ncbi.nlm.nih.gov/pubmed/34979235
http://dx.doi.org/10.1016/j.phrs.2021.106053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719379/
https://www.ncbi.nlm.nih.gov/pubmed/34979235
http://dx.doi.org/10.1016/j.phrs.2021.106053

Ejemplares similares